ArticleMedical sciences (Basel, Switzerland)2026
Linguistic and Clinical Validation of the Polish Version of the Walking Impairment Questionnaire.
Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntermittent claudication is one of the most common symptoms of peripheral arterial disease. The Walking Impairment Questionnaire (WIQ) is frequently used to assess patients suffering from intermittent claudication as it measures walking distance, speed, and ability to climb stairs. Although the questionnaire has been translated and employed in different countries, no validated Polish version is available yet. The aim of this study was to translate and validate the Polish version of the WIQ.
methodsOne hundred patients with IC who qualified for endovascular treatment were enrolled. WIQ translation and clinical validation was performed. The correlations among the WIQ, the two quality of life questionnaires (VascuQol-25 and SF-36), and objective walking distances in a 6-minute walking test (6 MWT) were calculated to determine the validity.
resultsCorrelations were observed among all WIQ domains, as well as between the total WIQ score and both initial claudication distance (InCD) and maximum walking distance (MWD), across all domains and 6 MWT parameters. The WIQ correlated with all domains of both VascuQol and SF-36. Test-retest reliability, as measured using the ICC, was 0.90. The internal consistency determined using Cronbach's alpha was 0.94 for the total WIQ score.
conclusionsThis study demonstrates that the Polish version of the WIQ, using the European metric system, is a reliable and clinically relevant tool for assessing walking impairment in patients with intermittent claudication.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.